Bayer and Curadev sign research collaboration and license agreement for STING antagonists Medical Dialogues Bureau25 March 2020 11:15 AM ISTBerlin & New Delhi: Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, has announced a research collaboration and license...
Bayer, Nuvisan ink pact to create new research unit in Berlin Medical Dialogues Bureau14 Feb 2020 10:30 AM ISTThe strategic partnership will lay the foundation for a brand-new research entity to be established by Nuvisan in Berlin. At the same time, it will...
Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea MD bureau2 Feb 2020 10:00 AM ISTBerlin: Bayer has submitted an application to the European Medicines Agency (EMA) for a pre-filled syringe to administer Eylea® (aflibercept solution...
Drugmajors slash prices by 53pc for China bulk-buy program eligibility Medical Dialogues Bureau20 Jan 2020 10:00 AM ISTBeijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
German drug assessment body not convinced by Bayer's cancer drug Vitrakvi Medical Dialogues Bureau19 Jan 2020 9:30 AM ISTFrankfurt: Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence...
Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche Medical Dialogues Bureau25 Nov 2019 9:00 AM ISTMedian overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq...
Bayer Roundup suits increase to 42700 Medical Dialogues Bureau1 Nov 2019 9:00 AM ISTA court-appointed mediator between Bayer and US plaintiffs in August denied reports the company had offered an $8 billion settlement to get the cases...
Bayer disagrees with German Government decision to ban Glyphosate from end of 2023 Medical Dialogues Bureau6 Sept 2019 9:00 AM IST"Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years...
Former JnJ executive Marianne De Backer to lead Bayer pharma division Medical Dialogues Bureau4 Sept 2019 9:30 AM ISTMarianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion Medical Dialogues Bureau21 Aug 2019 9:00 AM ISTBayer said in a statement that the sale, aimed at sharpening the company's focus on life sciences, was expected to be concluded in mid-2020 pending...
Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month Medical Dialogues Bureau17 Aug 2019 9:15 AM ISTRozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
Bayer buys BlueRock in USD 600 million bet on stem cell therapies Medical Dialogues Bureau9 Aug 2019 9:00 AM ISTFRANKFURT: German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up...
